Orange Book product · Generic (ANDA)
PIMOZIDE
PIMOZIDE
Generic (ANDA)ANDA 219897TE ABRX NOVITIUM PHARMA
At a glance
Apr 13, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 13, 2026
2 mo ago
Today
Exclusivity ends · CGT
FDA marketing exclusivity
Oct 18, 2026
in 4 mo
Pharmaceutical detail
Active ingredient
PIMOZIDE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 219897
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PIMOZIDE
Marketing exclusivity (1)
- CGTFDA marketing exclusivity
Oct 18, 2026
in 4 mo
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
